Wolverine Trading’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.47M | Buy |
21,900
+15,200
| +227% | +$1.01M | ﹤0.01% | 2492 |
|
|
2025
Q2 | $436K | Sell |
6,700
-23,400
| -78% | -$1.4M | ﹤0.01% | 3089 |
|
|
2025
Q1 | $1.85M | Buy |
30,100
+21,400
| +246% | +$1.42M | ﹤0.01% | 1697 |
|
|
2024
Q4 | $629K | Buy |
8,700
+1,000
| +13% | +$78.1K | ﹤0.01% | 3133 |
|
|
2024
Q3 | $622K | Sell |
7,700
-2,000
| -21% | -$160K | ﹤0.01% | 2847 |
|
|
2024
Q2 | $720K | Sell |
9,700
-2,600
| -21% | -$195K | ﹤0.01% | 2494 |
|
|
2024
Q1 | $959K | Sell |
12,300
-20,800
| -63% | -$1.55M | ﹤0.01% | 2238 |
|
|
2023
Q4 | $2.36M | Buy |
33,100
+17,600
| +114% | +$1.23M | ﹤0.01% | 1586 |
|
|
2023
Q3 | $1.08M | Buy |
+15,500
| New | +$1.17M | ﹤0.01% | 2065 |
|
|
2023
Q2 | – | Sell |
-7,200
| Closed | -$580K | – | 4536 |
|
|
2023
Q1 | $580K | Sell |
7,200
-10,200
| -59% | -$821K | ﹤0.01% | 2366 |
|
|
2022
Q4 | $1.3M | Sell |
17,400
-6,900
| -28% | -$491K | ﹤0.01% | 1661 |
|
|
2022
Q3 | $1.58M | Sell |
24,300
-3,300
| -12% | -$229K | ﹤0.01% | 1582 |
|
|
2022
Q2 | $1.94M | Buy |
27,600
+10,100
| +58% | +$750K | ﹤0.01% | 1400 |
|
|
2022
Q1 | $1.34M | Sell |
17,500
-27,000
| -61% | -$1.94M | ﹤0.01% | 2139 |
|
|
2021
Q4 | $3.41M | Buy |
44,500
+18,100
| +69% | +$1.33M | ﹤0.01% | 1412 |
|
|
2021
Q3 | $1.95M | Sell |
26,400
-1,000
| -4% | -$75K | ﹤0.01% | 2174 |
|
|
2021
Q2 | $1.89M | Buy |
27,400
+11,900
| +77% | +$796K | ﹤0.01% | 2041 |
|
|
2021
Q1 | $1.15M | Buy |
15,500
+1,300
| +9% | +$98.7K | ﹤0.01% | 2574 |
|
|
2020
Q4 | $1.02M | Sell |
14,200
-18,300
| -56% | -$1.29M | ﹤0.01% | 2359 |
|
|
2020
Q3 | $2.15M | Buy |
32,500
+13,400
| +70% | +$848K | 0.01% | 1423 |
|
|
2020
Q2 | $1.02M | Sell |
19,100
-12,900
| -40% | -$633K | ﹤0.01% | 1980 |
|
|
2020
Q1 | $1.12M | Sell |
32,000
-11,300
| -26% | -$538K | ﹤0.01% | 1813 |
|
|
2019
Q4 | $2.25M | Buy |
43,300
+2,300
| +6% | +$115K | 0.01% | 1740 |
|
|
2019
Q3 | $2.03M | Buy |
41,000
+6,900
| +20% | +$340K | 0.01% | 1425 |
|
|
2019
Q2 | $1.64M | Sell |
34,100
-21,800
| -39% | -$1.01M | ﹤0.01% | 1649 |
|
|
2019
Q1 | $2.71M | Sell |
55,900
-15,100
| -21% | -$681K | 0.01% | 1291 |
|
|
2018
Q4 | $2.87M | Buy |
71,000
+23,700
| +50% | +$972K | 0.01% | 1154 |
|
|
2018
Q3 | $1.94M | Buy |
47,300
+14,000
| +42% | +$566K | ﹤0.01% | 1701 |
|
|
2018
Q2 | $1.24M | Hold |
33,300
| – | – | ﹤0.01% | 2033 |
|
|
2018
Q1 | $1.24M | Sell |
33,300
-15,400
| -32% | -$622K | ﹤0.01% | 2033 |
|
|
2017
Q4 | $2.08M | Sell |
48,700
-10,600
| -18% | -$423K | 0.01% | 1517 |
|
|
2017
Q3 | $2.18M | Buy |
59,300
+3,000
| +5% | +$121K | 0.01% | 1269 |
|
|
2017
Q2 | $2.56M | Buy |
+56,300
| New | +$2.49M | 0.01% | 1076 |
|
|
2017
Q1 | – | Sell |
-41,000
| Closed | -$1.65M | – | 4572 |
|
|
2016
Q4 | $1.65M | Buy |
41,000
+21,400
| +109% | +$826K | 0.01% | 1488 |
|
|
2016
Q3 | $748K | Sell |
19,600
-8,400
| -30% | -$317K | ﹤0.01% | 2176 |
|
|
2016
Q2 | $954K | Buy |
+28,000
| New | +$970K | 0.01% | 1631 |
|
Other funds holding HOLX
BCIM
Wolverine Trading's HOLX Position: Q3 2025 in Review
Wolverine Trading reduced its Hologic (HOLX) stake by 71% in Q3 2025, selling an estimated $1.12M and leaving 6,841 shares worth $459K. The position accounts for ﹤0.01% of the portfolio, ranked #3807.
Wolverine Trading first reported a position in HOLX in Q3 2017 and has held it in 23 quarters since. The position peaked at $2.51M in Q2 2021. 738 funds tracked by Wall St. Rank hold HOLX as of Q3 2025.
- Wolverine Trading held 6,841 shares of Hologic worth $459K as of Q3 2025.
- Wolverine Trading sold 16,819 Hologic shares in Q3 2025, an estimated $1.12M.
- Hologic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #3807 holding.
- Wolverine Trading first reported a position in Hologic in Q3 2017 and has held it in 23 quarters since.
- Wolverine Trading's Hologic position peaked at $2.51M in Q2 2021.
- 738 funds tracked by Wall St. Rank held Hologic as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.